Checkpoint Therapeutics CEO James Oliviero's 2023 pay slips 20% to $1.6M
Checkpoint Therapeutics reports 2023 executive compensation
By ExecPay News
Published: April 2, 2024
Checkpoint Therapeutics reported fiscal year 2023 executive compensation information on April 2, 2024.
In 2023, two executives at Checkpoint Therapeutics received on average a compensation package of $1.2M, a 15% decrease compared to previous year.
Average pay of disclosed executives at Checkpoint Therapeutics
James F. Oliviero III, Chief Executive Officer, received $1.6M in total, which decreased by 20% compared to 2022. 44% of Oliviero's compensation, or $720K, was in stock awards. Oliviero also received $286K in non-equity incentive plan and $636K in salary.
Garrett Gray, Chief Financial Officer, received a compensation package of $713K, which is about the same as previous year. 44% of the compensation package, or $315K, was in salary.
Related executives
You may also like
Source: SEC filing on April 2, 2024.